InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: TheDane post# 137261

Saturday, 01/16/2016 11:54:17 AM

Saturday, January 16, 2016 11:54:17 AM

Post# of 403755
TD, hopefully the extension of the phase 1 Kevetrin trial at Harvard is for testing out multi-dosing Kevetrin weekly. Its something the company has been talking about for years. Leo already stated that they are not sure at what phase of the cell cycle Kevetrin will be most effective at. Multi-dosing could shed some light here and confirm what direction they want to take in the phase 2's.

Get FDA approval for modifying the protocol and have the safety board approve it and you already have everything else in place.